Sentinel community Clostridium difficile infection (CDI) surveillance in Scotland, April 2013 to March 2014

被引:15
|
作者
Banks, A. [1 ]
Brown, Derek J. [2 ]
Mather, Henry [2 ]
Coia, John E. [2 ]
Wiuff, Camilla [1 ]
机构
[1] NHS Natl Serv Scotland, Hlth Protect Scotland, Meridian Court, 5 Cadogan St, Glasgow G2 6QE, Lanark, Scotland
[2] Glasgow Royal Infirm, SSSCDRL, Level 5,New Lister Bldg,10-16 Alexandra Parade, Glasgow G31 2ER, Lanark, Scotland
关键词
Clostridium difficile; CDI; Surveillance; Community; Scotland; MOLECULAR EPIDEMIOLOGY; DISEASE; CARRIAGE; STRAINS; COUNTY; RISK;
D O I
10.1016/j.anaerobe.2015.12.008
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Surveillance of Clostridium difficile infection (CDI) in Scotland does not currently distinguish between CDI cases from hospitals and the community. Therefore, the incidence of CDI in the community is unknown, and the burden of disease and the relationship with the hospital/healthcare setting is not well understood. A one-year sentinel community surveillance programme was initiated in collaboration with five Scottish health boards in 2013 (representing 36% of all CDI cases reported in Scotland). Inclusion criteria were all cases aged >= 15 years with a CDI diagnosis in the community or within 48 h following admission to hospital. CDI cases were categorised according to definitions used by the European Centre for Disease Prevention and Control. 256 CDI cases met the inclusion criteria, of which 158 (62%) were community-associated cases (CA-CDI). This represented 26% of all cases reported during the surveillance period by the participating health boards (n = 614). The overall CA-CDI incidence rate was 9.9 per 100 000 population per year. CA-CDI cases were more likely to be female and younger, compared to hospital acquired cases (HA-CDI). The total proportion of cases that had onset in the community was 27%. Ribotypes 015, 002, 078 and 005 were the most common types isolated from both CA-CDI and HA-CDI cases. There were no statistically significant differences between the proportion of types that were either CA-CDI or HA-CDI. Of the CA-CDI cases, 37% had not received antibiotics in the 12 weeks preceding CDI diagnosis, 4% were resident in care homes, and the case-fatality rate for CA-CDI cases was 5.6% (with a 30-day mortality rate for CA-CDI of 0.44 per 100 000 population per year). This study has shown that a substantial proportion of CDI cases reported in Scotland are community associated and that there are close links between the community and healthcare settings. It is therefore essential to monitor the trends in CDI in the community at a national level. The study also provides evidence for the need to examine the feasibility for development of interventions to reduce the burden in the community in addition to hospitals. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 50 条
  • [31] FOXP3+Cd3-Cells in Clostridium difficile Infection (CDI)
    Yacyshyn, Mary Beth
    Harris, Nathaniel
    Yacyshyn, Bruce
    GASTROENTEROLOGY, 2014, 146 (05) : S251 - S252
  • [32] CLOSTRIDIUM-DIFFICILE INFECTION (CDI) - A POOR PROGNOSTIC SIGN IN UREMIC PATIENTS
    STENVINKEL, P
    BARANY, P
    NORD, CE
    BERGSTROM, J
    KIDNEY INTERNATIONAL, 1992, 41 (02) : 503 - 503
  • [33] Incidence and Risk Factors of Recurrent Clostridium difficile Infection (CDI) in Patients With Cirrhosis
    Ismail, Mayada
    Singh, Dharmvir
    Ascha, Mustafa S.
    Wong, Ken Koon
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1492 - S1492
  • [34] The effect of bezlotoxumab for prevention of recurrent Clostridium difficile infection (CDI) in Japanese patients
    Mikamo, Hiroshige
    Aoyama, Norihiro
    Sawata, Miyuki
    Fujimoto, Go
    Dorr, Mary Beth
    Yoshinari, Tomoko
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (02) : 123 - 129
  • [35] Admission Screening for Clostridium difficile Infection (CDI) in Bone Marrow Transplant Populations
    Tarabay, Jessica
    Varkey, Jay
    Ayers, Marie
    Soni, Tanushree
    Langston, Amelia
    Bracewell, Emily
    Bell, Christina
    Crain, Maria
    Hutcherson, Don
    Smiley, Mitzy
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S113 - S113
  • [36] THE SYSTEMIC INFLAMMATORY RESPONSE TO CLOSTRIDIUM DIFFICILE INFECTION (CDI) IN PATIENTS WITH ULCERATIVE COLITIS
    Limsrivilai, Julajak
    Rao, Krishna
    Stidham, Ryan W.
    Govani, Shail M.
    Waljee, Akbar K.
    Reinink, Andrew R.
    Johnson, Laura
    Briggs, Emily
    Higgins, Peter D.
    GASTROENTEROLOGY, 2017, 152 (05) : S760 - S760
  • [37] Community-acquired Clostridium difficile infection
    Kyne, L
    Merry, C
    O'Connell, B
    Keane, C
    O'Neill, D
    JOURNAL OF INFECTION, 1998, 36 (03) : 287 - 288
  • [38] Disease and Treatment Epidemiology of Initial Clostridium Difficile Infection (CDI) in a National Cohort
    Timbrook, Tristan
    Caffrey, Aisling
    Wang, Yan
    LaPlante, Kerry
    Morrill, Haley
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 78 - 79
  • [39] THE BURDEN OF CLOSTRIDIUM DIFFICILE (CDI) INFECTION IN HOSPITALS, IN DENMARK, FINLAND, NORWAY AND SWEDEN
    Nordling, S.
    Anttila, V. J.
    Noren, T.
    Cockburn, E.
    VALUE IN HEALTH, 2014, 17 (07) : A670 - A670
  • [40] Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score
    Cobo, Javier
    Merino, Esperanza
    Martinez, Cristina
    Cozar-Llisto, Alberto
    Shaw, Evelyn
    Marrodan, Teresa
    Calbo, Esther
    Bereciartua, Elena
    Sanchez-Munoz, Luis A.
    Salavert, Miguel
    Teresa Perez-Rodriguez, M.
    Garcia-Rosado, Dacil
    Maria Bravo-Ferrer, J.
    Galvez-Acebal, Juan
    Henriquez-Camacho, Cesar
    Cuquet, Jordi
    Pino-Calm, Berta
    Torres, Luis
    Sanchez-Porto, Antonio
    Fernandez-Felix, Borja M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (03) : 393 - 398